Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	21.33	53.88	44.41
Graham Fair Price	-32.61	3.68	5.46
PEG	-7.98	-0.43	0.47
Price/Book	-10.91	2.90	3.25
Price/Cash Flow	-76.73	53.65	-230.51
Prices/Earnings	108.57	24.62	11.81
Price/Sales	-13.63	9.62	11.13
Price/FCF	-76.73	53.65	-230.51
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-26.61	0.38	0.52
Operating Margin	-61.40	0.09	0.23
ROA	-55.33	0.01	0.03
ROE	0.07	0.03	-57.29
ROIC	0.03	0.01	-58.01
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.08	-0.05	-39.20
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.25	-0.59	132.02
EPS QOQ	0.25	-0.57	126.67
FCF QOQ	-1.18	4.95	319.93
Revenue QOQ	-0.05	0.06	21.30
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	258.41	181.50	-29.76
Days Sales Outstanding (DSO)	108.30	92.13	-14.93
Inventory Turnover	0.35	0.50	42.38
Debt/Capitalization	0.40	0.38	-4.26
Quick Ratio	0.83	0.85	2.59
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.38	4.52	3.12
Cash	0.77	0.91	18.24
Capex	-0.13	-0.16	-21.23
Free Cash Flow	-0.06	0.24	294.74
Revenue	1.28	1.36	6.36
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.52	1.65	8.06
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.71	6.99	4.19
Naive Interpretation	Member

06 - Financial Health · Weak

Rating